promot
paryl
member
eg
catalyz
maryl
hottig
ryu
et
al
gupt
et
al
new
nomenclatur
thu
propos
call
diphtheria
toxinlik
adpribosyltransferas
artd
eg
hottig
et
al
differ
parp
lead
divers
function
parp
biolog
process
innat
immun
respons
fig
parp
famili
member
contain
structur
domain
addit
catalyt
domain
one
domain
macrodomain
contain
call
macro
parp
macrodomain
bind
case
hydrolyz
adpribos
free
proteinbound
form
reader
adpribosyl
influenc
mani
biolog
process
rack
et
al
evid
link
macroparp
multipl
type
cancer
particularli
lymphoma
aguiar
et
al
cho
et
al
may
also
play
import
role
cell
morpholog
vya
et
al
found
interplay
regul
macrophag
activ
iwata
et
al
describ
review
differ
cellular
distribut
parp
may
also
indic
distinct
target
function
vya
et
al
found
nucleu
mostli
locat
cytoplasm
seen
nucleu
cytoplasm
adpribolyl
revers
eras
polyadpribos
glycohydrolas
parg
adpribosylhydrolas
macrodomain
miwa
sugimura
oka
et
al
jankeviciu
et
al
rosenth
et
al
parg
potent
enzym
degrad
polyadpribos
sever
isoform
deriv
singl
parg
gene
altern
splice
ie
protein
isoform
mostli
seen
nucleu
appear
play
domin
role
par
degrad
parg
eras
adpribos
bound
protein
leav
maryl
amino
acid
residu
parg
use
tool
enabl
research
abil
enrich
maryl
peptid
mass
spectrometri
analysi
adpribosyl
higashi
et
al
immun
cell
serv
import
role
immun
system
differenti
variou
subset
perform
spectrum
uniqu
function
balanc
number
differ
immun
cell
type
activ
level
crucial
health
diseas
overwhelm
evid
associ
chronic
inflamm
variou
patholog
condit
potenti
caus
includ
atherosclerosi
cardiovascular
event
cancer
autoimmun
diseas
metabol
disord
neurolog
diseas
age
johnston
et
al
fune
et
al
swirski
nahrendorf
orourk
et
al
variou
signaltransduct
pathway
particip
macrophag
activ
often
regul
ptm
phosphoryl
acetyl
tietzel
mosser
park
et
al
zhou
et
al
nakano
et
al
vergadi
et
al
dean
et
al
section
focus
impact
parp
adpribosyl
macrophag
activ
also
summar
role
biolog
immun
cell
evid
suggest
adpribosyl
particip
inflamm
bai
rosado
et
al
kunz
hottig
implic
mechan
respons
eg
proinflammatori
cytokin
express
macrophag
macrophagelik
cell
line
pathogenassoci
molecular
pattern
pamp
includ
lipopolysaccharid
lp
hassa
et
al
liu
et
al
yang
et
al
minotti
et
al
bohio
et
al
respons
involv
interplay
nuclear
factor
key
b
figur
parp
regul
innat
immun
respons
mani
differ
point
mechan
use
maryl
nonenzymat
parp
modul
ifn
proinflammatori
cytokin
induct
bind
rigi
promot
oligomer
initi
cascad
ii
also
bind
ifn
mrna
target
degrad
iii
shown
bind
trif
enhanc
gene
express
iv
adpribosyl
inhibit
phosphoryl
v
interact
adpribosyl
nemo
prevent
activ
ikk
vi
promot
acetyl
recruit
pol
ii
ifn
promot
vii
upon
phosphoryl
polyadpribosyl
promot
activ
b
mechan
use
maryl
nonenzymat
parp
modul
ifni
signal
bind
adpribosyl
ubiquitin
ligas
allow
interact
ubiquitin
ifnar
target
proteasomedepend
degrad
ii
interact
ubiquitin
histon
protein
lead
chromatin
remodel
enhanc
express
subset
isg
p
phosphat
group
adpr
adpribos
ac
acetyl
modif
yellow
ciricl
ubiquitin
transcript
factor
immun
variou
biolog
process
hassa
hottig
hassa
et
al
liu
et
al
minotti
et
al
bohio
et
al
kunz
hottig
use
mice
oliv
et
al
provid
evid
promot
activ
macrophag
vivo
studi
demonstr
delet
caus
resist
lpsinduc
endotox
shock
ino
induct
product
recent
evid
suggest
phosphoryl
result
paryl
subunit
induc
transcript
gene
fig
bohio
et
al
also
induc
releas
highmobl
group
box
proinflammatori
factor
nucleu
cytoplasm
macrophag
requir
paryl
subsequ
acetyl
ditsworth
et
al
yang
et
al
also
exert
proinflammatori
effect
macrophagerel
cell
type
kupffer
cell
fatti
liver
microglia
injur
brain
ullrich
et
al
mukhopadhyay
et
al
case
activ
proinflammatori
mediat
depend
enzymat
activ
suggest
mechan
use
impact
inflamm
depend
context
target
hassa
et
al
minotti
et
al
role
nicotinamid
adenin
dinucleotid
nad
macrophag
activ
parp
catalyz
transfer
adpribos
nad
target
protein
henc
nad
consum
parp
activ
parp
depend
avail
nad
gupt
et
al
recent
report
indic
cellautonom
product
nad
via
kynurenin
pathway
kp
requir
induc
normal
inflammatori
macrophag
activ
de
novo
nad
synthesi
impair
age
macrophag
minha
et
al
anoth
studi
propos
mechan
link
nad
salvag
pathway
lpsinduc
consumpt
nad
cameron
et
al
lpsstimul
macrophag
increas
reactiv
oxygen
speci
induc
dna
damag
turn
activ
lead
reduct
avail
nad
nicotinamid
phosphoribosyltransferas
nampt
therefor
increas
maintain
nad
level
crucial
normal
inflammatori
macrophag
activ
particip
biolog
immun
cell
modul
differenti
cell
effector
cell
helper
helper
regulatori
cell
treg
saenz
et
al
nasta
et
al
defici
murin
cell
lead
increas
express
cytokin
decreas
product
cytokin
interleukin
saenz
et
al
suppress
secret
differenti
promot
express
via
chromatin
modif
locu
saenz
et
al
although
involv
differenti
cell
helper
cell
impact
treg
cell
augment
multipl
organ
mice
nasta
et
al
use
mice
nasta
et
al
demonstr
supress
express
thu
gener
treg
via
modul
chromatin
structur
andor
regul
transcript
factor
addit
studi
use
mice
demonstr
mechan
suppress
treg
via
transform
growth
factor
tgf
receptor
recent
report
demonstr
interact
role
maintain
number
function
cell
promot
develop
function
b
cell
navarro
et
al
galindocampo
et
al
defect
thymocyt
matur
observ
mice
accordingli
tcell
number
peripher
blood
reduc
galindocampo
et
al
mice
develop
bone
marrow
b
cell
impair
lead
reduct
transit
follicular
b
cell
navarro
et
al
also
play
role
matur
function
dendrit
cell
regul
product
aldinucci
et
al
seri
vivo
studi
boular
matter
group
oumounabenachour
et
al
von
lukowicz
et
al
han
et
al
han
et
al
use
mice
demonstr
promot
develop
variou
cardiovascular
disord
two
studi
report
defici
apolipoprotein
edefici
apo
mice
reduc
size
macrophag
tcell
content
death
macrophag
foam
cell
necrot
core
nfkb
activ
adhes
molecul
express
experiment
atherosclerot
lesion
typic
featur
human
plaqu
prone
acut
thrombot
event
oumounabenachour
et
al
von
lukowicz
et
al
delet
attenu
dyslipidemiainduc
vascular
dysfunct
apo
mice
seemingli
via
mainten
eno
activ
han
et
al
defici
furthermor
improv
delat
cardiomyophathi
concomitantli
increas
tissu
inhibitor
metalloproteinas
apo
mice
han
et
al
mani
report
suggest
multipl
proinflammatori
role
contribut
parp
famili
member
macrophag
activ
remain
incomplet
understood
demonstr
coregul
proinflammatori
activ
human
macrophag
iwata
et
al
studi
took
systemsbiolog
approach
involv
unbias
proteom
bioinformat
network
analysi
identifi
potenti
molecular
switch
balanc
proinflammatori
versu
nonantiinflammatori
macrophag
phenotyp
potenti
therapeut
target
perform
proteom
human
mous
macrophagelik
cell
line
treat
repres
socal
proinflammatori
versu
nonantiinflammatori
cell
process
proteom
data
protein
convent
filter
method
well
origin
cluster
method
ricchiuto
et
al
identifi
molecul
increas
decreas
iwata
et
al
interestingli
protein
emerg
stringent
criteria
also
recogn
show
similar
respons
studi
demonstr
vitro
suppress
proinflammatori
signal
activ
antiinflammatori
pathway
primari
human
macrophag
fig
iwata
et
al
silenc
sirna
acceler
induct
proinflammatori
cytokin
chemokin
eg
macrophag
suppress
antiinflammatori
molecul
eg
cell
silenc
gener
exert
oppos
effect
also
appear
interfer
suppress
action
axi
thu
promot
proinflammatori
macrophag
activ
fig
cellfre
enzym
reaction
mass
spectrometri
readout
indic
adpribosyl
may
reduc
phosphoryl
proinflammatori
mediat
howev
mechan
use
interact
influenc
adpribosyl
phosphoryl
requir
investig
due
wellrecogn
knowledg
target
identifi
basic
scienc
often
fail
clinic
stage
perform
network
analysi
close
link
network
first
neighbor
interactor
human
coronari
arteri
diseas
gene
modul
fig
predict
vivo
studi
mice
demonstr
particip
pathogenesi
arteri
diseas
consist
vitro
studi
defici
inde
mitig
lesion
develop
inflammatori
burden
model
coronari
arteri
diseas
mice
iwata
et
al
antiinflammatori
role
report
us
consist
report
iqbal
et
al
demonstr
macrophag
reduc
mrna
stabil
thu
express
level
tissu
factor
surfac
glycoprotein
play
major
thrombogen
role
macrophagerich
atherosclerot
lesion
associ
antiflammatori
first
describ
use
yeast
twohybrid
screen
goenka
boothbi
although
subsequ
studi
done
context
macrophag
activ
indic
enhanc
transcript
activ
may
relev
promot
bind
function
rather
potenti
adpribosyl
fig
goenka
et
al
mehrotra
et
al
instanc
act
transcript
repressor
target
gene
activ
lead
autoribosyl
dissoci
dnaprotein
complex
therebi
promot
bind
instead
fig
goenka
et
al
mehrotra
et
al
thu
despit
accumul
evid
promot
antiinflammatori
state
yet
exist
enough
inform
disentangl
enzymat
function
proteininteract
function
function
may
maintain
antiinflammatori
respons
irrespect
cytokin
stimulu
evid
establish
macrophag
heterogen
group
cell
repres
wellknown
theori
versu
polar
recent
understand
howev
suggest
macrophag
heterogen
complex
multidimension
dichotomi
murray
et
al
nahrendorf
swirski
decano
aikawa
studi
singlecel
analysi
demonstr
macrophag
remain
larg
heterogen
consist
cluster
rather
uniformli
polar
toward
activ
phenotyp
iwata
et
al
gene
similar
map
demonstr
close
interact
support
vitro
data
describ
sever
piec
evid
demonstr
promot
differenti
cell
cell
figur
partial
model
function
macrophag
activ
vivo
vitro
studi
pertain
ifng
signal
primarili
macrophag
suggest
mitig
proinflammatori
phosphoryl
via
adpribosyl
may
act
inhibit
enzymat
activ
iwata
et
al
vitro
studi
pertain
signal
context
bcell
biolog
suggest
nonstimul
condit
suppressor
target
gene
respons
thought
becom
enzymat
activ
dissoci
promot
therebi
allow
phosphoryl
bind
activ
target
gene
mehrotra
et
al
green
question
mark
indic
fate
adpribosyl
substrat
known
mechan
appear
distinct
may
partial
complementari
pictur
complex
biolog
fehr
et
al
regul
express
mice
show
reduc
symptom
allerg
airway
diseas
riley
et
al
enhanc
differenti
mehrotra
et
al
also
implic
immunoglobulin
class
switch
b
cell
enhanc
signal
produc
ige
isotyp
major
factor
allerg
hypersensit
mehrotra
et
al
discuss
sever
studi
report
promot
suppress
macrophag
activ
via
signal
pathway
eg
evid
remain
scant
role
parp
play
macrophag
biolog
lp
increas
mrna
express
murin
bone
marrowderiv
macrophag
known
function
parp
macrophag
biolog
caprara
et
al
report
link
signal
verheugd
et
al
welsbi
et
al
although
line
evid
may
suggest
role
parp
macrophag
biolog
investig
need
better
understand
parp
particip
macrophag
activ
inflammatori
diseas
parp
target
drug
develop
particularli
cancer
field
activ
target
includ
recent
berger
et
al
qin
et
al
studi
use
small
molecul
inhibitor
demonstr
parp
suppress
reduc
proinflammatori
respons
enhanc
antiinflammatori
function
macrophag
et
al
wang
et
al
shrestha
et
al
dharwal
et
al
recent
work
show
parp
inhibit
combin
blockad
could
effect
tumor
activ
antigen
present
cell
dendrit
cell
via
cgasst
pathway
jiao
et
al
ding
et
al
dunphi
et
al
major
effect
report
studi
may
reflect
suppress
inhibitor
howev
strictli
specif
effect
parp
member
target
parp
thu
need
address
wahlberg
et
al
global
view
parp
activ
immun
undoubtedli
requir
proteom
howev
even
advanc
mass
spectrometri
technolog
avail
disentangl
uniqu
overlap
function
parp
remain
challeng
hand
figur
comput
predict
associ
network
human
inflammatori
diseas
network
blue
purpl
consist
protein
directli
interact
parp
blue
orang
node
respect
pvalu
indic
signific
close
first
neighbor
interactom
modul
gene
modul
human
diseas
coronari
arteri
diseas
compar
random
expect
reproduc
iwata
et
al
studi
begun
interrog
complex
biolog
parp
famili
member
context
immun
nearli
year
ago
radioact
label
strategi
demonstr
increas
adpribosyl
signal
human
monocytederiv
macrophag
respons
berton
et
al
addit
increas
mrna
implic
addit
mechan
rather
increas
total
level
increas
adpribosyl
use
quantit
proteom
made
similar
observ
macrophagelik
cell
line
iwata
et
al
moreov
exhibit
increas
express
follow
exposur
opposit
respons
decreas
abund
stimul
period
contrast
proinflammatori
antiinflammatori
respons
distinct
parp
measur
studi
specif
respons
characterist
known
cytokin
induc
gene
nmi
nmyc
interactor
among
sever
other
studi
thu
provid
plausibl
scenario
increas
global
adpribosyl
macrophag
could
mediat
part
iwata
et
al
separ
studi
use
quantit
proteom
combin
shrnamedi
knockdown
experi
interactor
pursu
context
lp
signal
cell
caprara
et
al
coimmunoprecipit
cell
lp
treatment
found
receptor
link
autophagi
ubiquityl
nmi
immunoprecipit
antibodi
specif
wildtyp
knockdown
cell
indic
protein
form
interact
network
respons
lp
proteinprotein
interact
alon
clarifi
role
parp
enzym
activ
immun
date
one
studi
investig
adpribosyl
substrat
immun
cell
global
level
higashi
et
al
sinc
adpribosylom
studi
technic
challeng
perform
reli
special
proteom
workflow
enrich
sequenc
adpriboysl
peptid
martello
et
al
larsen
et
al
use
two
independ
approach
enrich
adpribosylom
cell
one
approach
use
antiparyl
antibodi
enrich
provid
candid
adpribosyl
protein
enrich
maryl
peptid
via
affin
macrodomain
identifi
adpribosyl
protein
higashi
et
al
major
protein
identifi
approach
combin
compris
ribosomernabind
protein
find
surpris
sinc
protein
class
highli
abund
therebi
conduc
identifi
adpribosyl
peptid
adpribosyl
protein
associ
pathway
involv
neutrophil
degranul
activ
signal
glycolysi
moreov
adpribosyl
subset
ribosomernabind
protein
increas
respons
adpribosyl
form
interestingli
ubiquitin
pathway
associ
protein
identifi
candid
bind
partner
caprara
et
al
studi
point
toward
adpribosyl
link
macrophag
activ
protein
homeostasi
indic
chang
adpribosyl
numer
translat
machineri
emerg
protein
involv
ubiquitin
higashi
et
al
adpribosyl
wellknown
play
import
role
mani
hostpathogen
interact
instanc
mani
import
bacteri
toxin
adpribosyltransferas
art
bacteri
pathogen
b
pertussi
v
cholera
p
aeruginosa
c
botulinum
aureu
e
coli
encod
art
target
protein
elong
factor
actin
rho
gtpase
lead
cell
death
holbourn
et
al
discuss
mammal
also
encod
divers
set
art
term
parp
impact
infect
discuss
mammalian
encod
parp
involv
hostpathogen
interact
focus
viru
infect
parp
interact
pathogen
mani
way
describ
specif
case
either
promot
restrict
viru
replic
innat
immun
respons
discuss
summar
tabl
figur
howev
start
discuss
characterist
indic
import
role
parp
host
respons
infect
first
mani
mammalian
parp
stimul
product
ifn
ifnstimul
gene
isg
thu
part
mammalian
antivir
defens
system
atasheva
et
al
zhang
et
al
eckei
et
al
li
et
al
grunewald
et
al
also
sever
monoadpribosyl
parp
rapidli
evolv
indic
ongo
conflict
pathogen
parp
domain
disord
region
macrodomain
three
macroparp
posit
select
kern
et
al
daugherti
et
al
furthermor
undergon
multipl
round
gene
loss
duplic
creat
novel
gene
product
need
continu
adapt
new
pathogen
sever
parp
protein
also
present
stress
granul
import
membraneless
organel
function
restrict
translat
rna
cell
stress
viru
infect
often
character
presenc
tiar
known
contain
sever
hundr
protein
mccormick
khaperskyy
interestingli
sever
protein
stress
granul
adpribosyl
parp
includ
known
constitu
stress
granul
leung
et
al
propos
polyadpribos
facilit
concentr
rnabind
protein
stress
granul
nonmembran
structur
therebi
promot
oligomer
leung
sever
decad
ago
conserv
domain
identifi
coronavirus
cov
togavirus
hepat
e
viru
et
al
kameoka
et
al
kameoka
et
al
kameoka
et
al
baekelandt
et
al
ha
et
al
gwack
et
al
ariumi
et
al
parent
et
al
tempera
et
al
bueno
et
al
chung
et
al
gradi
et
al
liu
et
al
liu
et
al
b
cold
spring
harbor
laboratori
press
march
publish
genesdevcshlporg
download
term
x
domain
gorbalenya
et
al
koonin
et
al
domain
structur
homolog
nonhiston
part
protein
known
macrodomain
allen
et
al
macrodomain
three
viral
famili
bind
monoand
polyadpribos
effici
remov
monoadpribos
protein
hydrolysi
strongli
indic
role
adpribosyl
either
promot
inhibit
replic
virus
egloff
et
al
li
et
al
sever
studi
cov
alphaviru
macrodomain
establish
protein
domain
critic
either
replic
pathogenesi
eriksson
et
al
park
griffin
fehr
et
al
fehr
et
al
mcpherson
et
al
recent
studi
use
chikungunya
viru
chikv
macrodomain
mutant
show
macrodomain
adpribos
bind
facilit
initi
viru
replic
hydrolas
activ
essenti
amplif
replic
complex
abraham
et
al
infect
adpribosylhydrolas
arh
defici
cov
includ
sever
acut
respiratori
syndrom
sar
cov
murin
hepat
viru
mhv
led
higher
level
ifn
cytokin
indic
may
block
innat
immun
respons
fehr
et
al
grunewald
et
al
arhdefici
mhv
replic
poorli
primari
macrophag
importantli
defect
could
partial
rescu
parp
inhibitor
directli
indic
parp
antivir
respons
cov
grunewald
et
al
howev
remain
unknown
protein
may
target
viral
macrodomain
review
see
fehr
et
al
leung
et
al
first
report
parp
adpribosyl
impact
viru
infect
focus
role
retroviru
integr
replic
et
al
first
demonstr
parp
inhibitor
led
reduc
retrovir
integr
host
chromatin
use
antisens
oligonucleotid
overexpress
dominantneg
confirm
parp
activ
requir
integr
retrovir
vector
group
demonstr
import
parp
activ
retroviru
integr
host
chromosom
use
sirna
transfect
cell
ha
et
al
kameoka
et
al
mechanist
suggest
may
help
resolv
gap
genom
produc
integr
ha
et
al
activ
may
also
impact
transcript
replic
kameoka
et
al
kameoka
et
al
howev
result
confound
report
demonstr
either
evid
requir
effici
integr
replic
baekelandt
et
al
ariumi
et
al
evid
repress
retroviru
infect
parent
et
al
bueno
et
al
bueno
et
al
found
inhibit
retrovir
infect
chicken
b
lymphoblastoid
cell
line
parent
et
al
show
could
bind
transactiv
respons
element
tar
inhibit
transcript
compet
tar
bind
impact
infect
remain
controversi
like
contextdepend
addit
role
regul
retroviru
replic
paryl
enhanc
repress
sever
virus
includ
herpesvirus
parp
wide
rang
effect
tankyras
modifi
ebv
protein
paryl
caus
dissoci
dyad
symmetri
element
restrict
orip
bind
impair
mainten
viral
episom
latenc
deng
et
al
tempera
et
al
also
bind
tr
sequenc
kshv
lead
reduc
viral
genom
level
latenc
kinas
hkfc
synergist
bind
adpribosylatephosphoryl
herpesviru
replic
transcript
activ
protein
rta
fig
interact
suppress
rtamedi
transcript
activ
kshv
lytic
reactiv
gwack
et
al
two
mechan
describ
counter
activ
first
found
bind
prevent
interact
rta
fig
addit
process
factor
kshv
bind
target
degrad
reduc
paryl
rta
enhanc
viru
replic
fig
noh
et
al
chung
et
al
contrast
antivir
effect
parp
infect
parp
activ
seem
promot
replic
prototyp
express
increas
transloc
nucleu
infect
knockdown
result
threefold
fourfold
decreas
viru
replic
inhibit
catalyt
activ
result
greater
reduct
viru
replic
li
et
al
indic
parp
activ
import
viru
replic
infect
significantli
increas
paryl
protein
target
nuclear
form
par
glycohydrolas
parg
enzym
degrad
par
ubiquitin
degrad
provid
possibl
mechan
dramat
increas
paryl
infect
fig
gradi
et
al
final
polyadpribosyl
implic
provir
activ
sever
viral
system
parp
inhibitor
led
greatli
reduc
infect
adenovirus
possibl
adpribosyl
core
protein
et
al
parp
inhibitor
also
inhibit
jc
viru
replic
nukuzuma
et
al
bind
porcin
reproduct
respiratori
syndrom
viru
prrsv
nucleocapsid
protein
parp
inhibitor
restrict
replic
prrsv
cell
cultur
liu
et
al
nucleocapsid
protein
relat
coronavirus
also
adpribosyl
howev
impact
modif
viru
replic
pathogenesi
remain
unknown
grunewald
et
al
last
parp
activ
requir
effici
activ
rna
polymeras
deriv
multipl
strain
influenza
viru
indic
potenti
provir
role
adpribosyl
influenza
infect
bortz
et
al
summari
paryl
varieti
differ
function
repress
enhanc
viru
replic
role
nonenzymat
monoadpribosyl
parp
viru
replic
antivir
respons
nonenzymat
monoadpribosyl
parp
varieti
role
promot
inhibit
viru
replic
class
parp
includ
zinc
finger
znf
parp
macrodomaincontain
parp
sever
parp
fit
specif
categori
discuss
known
parp
innat
immun
respons
virus
znf
parp
contain
one
znf
domain
domain
small
protein
motif
enabl
parp
bind
rna
three
znf
parp
use
domain
interact
viral
rna
inhibit
either
translat
degrad
viral
rna
though
specif
rna
sequenc
parp
bind
like
uniqu
addit
three
znf
parp
use
either
enzymat
nonenzymat
function
parp
domain
impact
innat
immun
respons
viru
replic
znf
antivir
protein
znf
antivir
protein
zap
one
first
parp
identifi
antivir
activ
screen
antivir
isg
found
potent
inhibit
murin
leukemia
viru
mlv
replic
gao
et
al
somewhat
surprisingli
zap
lack
triad
motif
hye
need
catalyt
activ
autoadpribosyl
activ
klein
et
al
antivir
activ
independ
adpribosyl
sinc
discoveri
zap
shown
inhibit
replic
sever
viral
famili
includ
retrovirus
alphavirus
filovirus
picornavirus
herpesvirus
arterivirus
orthomyxovirus
flavivirus
hepat
b
viru
bick
et
al
muller
et
al
zhu
et
al
wang
et
al
xuan
et
al
mao
et
al
xuan
et
al
li
et
al
li
et
al
chiu
et
al
xie
et
al
zhao
et
al
zap
transcrib
four
differ
isoform
zapl
zap
studi
zapl
contain
inact
parp
catalyt
domain
zap
zapl
tend
greater
antivir
activ
may
due
least
part
prenyl
parp
domain
charron
et
al
schwerk
et
al
addit
parp
domain
zap
contain
four
znfbind
domain
singl
wwe
domain
zap
use
znfbind
domain
bind
viral
rna
recruit
poli
specif
ribonucleas
parn
rna
exosom
degrad
viral
rna
guo
et
al
also
inhibit
translat
block
interact
abil
block
translat
requir
degrad
rna
addit
zap
antivir
activ
enhanc
ubiquitin
ligas
activ
bind
zap
ubiquitin
unknown
protein
enhanc
antivir
activ
zap
li
et
al
zheng
et
al
zap
target
hiv
rna
degrad
prefer
target
cg
dinucleotid
takata
et
al
consist
mutant
increas
cg
content
replic
poorli
cell
replic
restor
zapdefici
cell
addit
zap
target
utr
japanes
enceph
viru
jev
contain
high
cg
content
chiu
et
al
interestingli
appear
mani
virus
maintain
low
cg
dinucleotid
level
level
zap
sensit
sever
virus
mildli
correl
cg
dinucleotid
content
takata
et
al
howev
zap
sensit
panel
alphavirus
correl
cg
dinucleotid
content
found
genom
individu
viral
gene
suggest
cg
dinucleotid
motif
determin
zap
recognit
local
zap
stress
granul
also
appear
function
import
antivir
activ
alphavirus
zap
mutant
local
sg
unabl
block
sinv
replic
law
et
al
vivo
zap
knockout
mice
show
enhanc
replic
sinv
mice
expect
kozaki
et
al
though
surprisingli
weanl
pup
shown
neurovirul
strain
sinv
use
zap
decreas
replic
initi
infect
cell
vivo
prevent
immun
recognit
allow
viru
spread
central
nervou
system
cn
promot
diseas
wang
et
al
addit
differ
studi
found
conflict
result
regard
abil
zap
impact
innat
immun
respons
origin
found
zap
zapl
potenti
rigidepend
type
interferon
ifni
product
human
cell
bind
rigi
via
znf
domain
promot
oligomer
fig
hayakawa
et
al
chiu
et
al
howev
zap
appear
enhanc
rigidepend
ifni
product
mous
cell
lee
et
al
recent
data
indic
zap
may
also
reduc
ifn
mrna
bind
utr
ifn
mrna
target
degrad
fig
schwerk
et
al
conceiv
zap
use
function
contextdepend
manner
zapl
contain
activ
parp
domain
case
requir
adpribosyl
protein
instanc
c
terminu
zapl
bind
influenza
viru
polymeras
protein
pa
caus
subsequ
polyadpribosyl
ubiquitin
degrad
liu
et
al
unknown
parp
ubiquitin
ligas
mediat
effect
knockdown
zapl
modestli
increas
influenza
viru
replic
cell
cultur
though
clear
whether
due
abil
bind
target
pa
degrad
interestingli
zapl
activ
counter
protein
bound
zapl
prevent
ubiquitin
pa
demonstr
viru
evolv
way
neutral
antivir
activ
zap
fig
addit
sever
viral
protein
found
counter
zap
use
multipl
mechan
fig
influenza
prevent
zap
bind
target
rna
tang
et
al
rta
disrupt
intermolecular
interact
zap
xuan
et
al
degrad
zap
mrna
su
et
al
final
enteroviru
ev
proteas
cleav
zap
protein
due
broadspectrum
antivir
activ
like
even
viral
protein
function
counter
zap
monoadpribosyltransferas
four
five
ntermin
ccchtype
zinc
finger
znf
domain
import
rna
bind
one
two
wwe
domain
middl
protein
import
adpribos
bind
parp
domain
c
terminu
provid
protein
monoadpribosyl
activ
welsbi
et
al
two
splice
form
mrna
atasheva
et
al
contain
znf
domain
parp
catalyt
domain
znf
domain
lack
parp
catalyt
domain
describ
transloc
cytoplasm
stress
granul
upon
cell
stress
leung
et
al
welsbi
et
al
initi
local
transgolgi
network
tgn
transloc
stress
granul
stress
stimuli
sever
differ
cell
type
activ
link
znf
domain
mutat
znf
domain
abrog
abil
move
stress
granul
welsbi
et
al
transloc
may
also
depend
act
stress
sensor
nucleu
increas
unconjug
par
key
factor
promot
recruit
stress
granul
catara
et
al
transloc
stress
granul
revers
reloc
back
golgi
stress
reliev
antivir
role
first
describ
overexpress
screen
mildli
inhibit
replic
vsv
liu
et
al
shortli
anoth
studi
found
differenti
express
cell
clear
veev
replic
compar
persist
infect
atasheva
et
al
analysi
show
express
veev
replicon
viru
restrict
veev
replic
well
sever
virus
includ
sindbi
viru
sinv
encephalomyocard
viru
emcv
vesicular
stomat
viru
vsv
rift
valley
fever
viru
rvfv
chikungunya
viru
chikv
subsequ
group
show
strongli
inhibit
cellular
viral
translat
atasheva
et
al
immunoprecipit
identifi
sever
ribosom
protein
translat
elong
factor
indic
interact
ribosom
interestingli
requir
enzymat
activ
block
translat
inhibit
viru
replic
indic
may
use
distinct
mechan
block
viru
replic
cellular
translat
addit
identifi
screen
isg
inhibit
zika
viru
zikv
use
knockout
cell
overexpress
author
show
necessari
suffici
inhibit
zikv
replic
requir
adpribosyl
ubiquitin
subsequ
degrad
zikv
protein
activ
requir
either
znf
wwe
domain
parp
requir
catalyt
domain
inact
catalyt
domain
revers
regulatori
effect
viral
protein
degrad
interestingli
appear
polyadpribosyl
indic
may
work
anoth
parp
mediat
polyadpribosyl
protein
also
role
restrict
coronaviru
cov
replic
sirna
knockdown
partial
restor
replic
mhv
lack
adpribosylhydrolas
arh
activ
cov
macrodomain
grunewald
et
al
mechan
use
restrict
mhv
replic
remain
unknown
final
also
shown
enhanc
signal
possibl
interact
trif
fig
welsbi
et
al
tiparp
also
known
tetrachlorodibenzopdioxin
tcdd
induc
polyadpribos
polymeras
tiparp
singl
znf
domain
mediat
rna
bind
also
wwe
domain
parp
catalyt
domain
capabl
monoadpribosyl
kozaki
et
al
like
tiparp
also
shown
block
veev
replic
inhibit
cellular
translat
transduc
cell
veev
replicon
atasheva
et
al
separ
studi
sirna
knockdown
tiparp
human
astrocyt
cell
led
increas
replic
sinv
rubella
viru
replic
kozaki
et
al
increas
sinv
replic
also
demonstr
tiparp
mice
tiparpmedi
inhibit
sinv
depend
znf
domain
bind
sinv
rna
recruit
rna
degrad
factor
site
viral
replic
suggest
tiparp
recogn
specif
viru
rna
degrad
howev
target
specif
tiparp
still
unknown
tiparp
also
provir
effect
addit
antivir
function
tiparp
neg
regul
type
ifn
respons
adpribosyl
fig
yamada
et
al
adpribosyl
kinas
domain
suppress
ifn
product
suggest
neg
regul
ifn
product
tiparp
may
help
protect
cell
harm
effect
type
ifn
studi
found
loss
tiparp
led
decreas
iav
replic
strongli
correl
increas
ifni
product
group
also
found
sirna
knockdown
tiparp
led
decreas
replic
mhv
increas
ifni
product
indic
tiparp
provir
factor
virus
grunewald
et
al
b
howev
remain
unclear
whether
abil
tiparp
enhanc
mhv
iav
replic
tie
abil
block
ifni
respons
macro
parp
contain
two
three
macrodomain
mediat
bind
adpribos
describ
macrodomain
cleav
adpribos
substrat
like
macrodomain
within
parp
protein
bind
adpribos
three
macro
parp
rapidli
evolv
daugherti
et
al
identifi
stress
granul
leung
et
al
howev
direct
evid
involv
viru
infect
limit
studi
identifi
role
modul
viru
infect
innat
immun
respons
thu
discuss
origin
term
baggress
lymphoma
gene
identifi
risk
factor
larg
diffus
bcell
lymphoma
aguiar
et
al
catalyt
inact
least
express
adpribosyl
ubiquitin
presenc
ubiquitin
ligas
yang
et
al
describ
promot
phosphoryl
proinflammatori
gene
express
differenti
macrophag
iwata
et
al
antivir
respons
express
malign
bcell
lymphoma
line
lead
widespread
induct
isg
express
juszczynski
et
al
zhang
et
al
found
complex
attach
mediat
hyperrespons
mutant
protein
complex
ubiquitin
histon
protein
notabl
led
chromatin
remodel
enhanc
express
least
subset
isg
fig
interact
necessari
suffici
inhibit
replic
multipl
virus
includ
emcv
iav
sinv
complex
also
ubiquitin
emcv
proteas
led
degrad
effect
mostli
complet
due
activ
origin
identifi
collabor
goenka
boothbi
rang
effect
cell
physiolog
immun
larg
antiinflammatori
cho
et
al
cho
et
al
barbarulo
et
al
vya
et
al
iansant
et
al
iwata
et
al
krishnamurthi
kaplan
antivir
respons
instead
requir
enhanc
ifni
product
raw
cell
transform
periton
macrophag
follow
lp
treatment
caprara
et
al
primari
macrophag
cell
cov
infect
follow
treatment
human
cell
poli
c
grunewald
et
al
follow
lp
treatment
cell
show
similar
level
phosphoryl
nuclear
transloc
reduc
level
pol
ii
recruit
promot
gene
caprara
et
al
also
dramat
reduct
acetyl
known
marker
activ
promot
enhanc
fig
unclear
whether
function
depend
catalyt
activ
also
yet
known
whether
function
cellular
respons
viru
infect
poli
c
two
studi
also
found
requir
restrict
replic
typhimurium
arhdefici
mhv
though
known
whether
abil
inhibit
pathogen
tie
role
upregul
ifn
product
whether
distinct
function
import
note
experi
done
undifferenti
macrophag
studi
found
antiinflammatori
function
use
macrophag
differenti
treatment
suggest
function
like
contextdepend
final
class
parp
fit
defin
class
parp
similar
domain
parp
domain
thu
simpli
term
parp
parp
includ
parp
defin
domain
besid
parp
domain
neither
known
role
immun
respons
rapidli
evolv
describ
earlier
report
direct
antivir
provir
activ
promot
er
stress
respons
adpribosyl
perk
jwa
chang
also
adpribosyl
karyopherin
indic
potenti
role
nuclear
transport
di
paola
et
al
howev
also
known
antivir
activ
impact
innat
immun
respons
focu
contain
rna
recognit
motif
rrm
nuclear
import
export
signal
two
ubiquitininteract
motif
uim
addit
catalyt
domain
verheugd
et
al
highli
upregul
ifn
eckei
et
al
grunewald
et
al
along
inhibit
veev
replic
block
protein
translat
express
veev
replicon
atasheva
et
al
also
block
signal
product
proinflammatori
cytokin
verheugd
et
al
mechanist
uim
interact
ubiquitin
chain
nemo
adpribosyl
nemo
prevent
polyubiquitin
ultim
block
transloc
nucleu
activ
gene
express
fig
remain
unknown
whether
function
impact
hostpathogen
interact
whether
function
context
second
smallest
parp
protein
smallest
singl
wwe
domain
addit
art
domain
also
highli
upregul
ifn
grunewald
et
al
recent
shown
block
ifn
signal
adpribosyl
ubiquitin
ligas
repeatcontain
protein
lead
ubiquitin
degrad
interferon
receptor
ifnar
fig
guo
et
al
sirna
silenc
treatment
rucaparib
panparp
inhibitor
use
advanc
ovarian
cancer
inhibit
replic
vsv
normal
known
inhibit
concentr
drug
use
studi
rucaparib
appear
preferenti
target
interestingli
follow
infect
vivo
rucaparib
enhanc
ifni
signal
reduc
vsv
replic
multipl
organ
led
better
outcom
mice
infect
either
vsv
data
indic
inhibitor
could
use
mean
treat
specif
viral
infect
summari
sever
nonenzymat
monoadpribosyl
parp
potent
antivir
protein
abl
inhibit
virus
sever
differ
viral
famili
howev
contain
activ
promot
viru
replic
mechan
known
includ
block
translat
degrad
rna
target
viral
host
protein
ubiquitin
degrad
mani
mechan
still
unknown
howev
recent
report
make
clear
mani
case
adpribosyl
tie
protein
homeostasi
either
mediat
translat
ubiquitinationdepend
protein
degrad
addit
sever
studi
identifi
multipl
point
innat
immun
respons
modul
parp
adpribosyl
fig
identif
similar
potenti
novel
process
mediat
parp
viru
infect
like
uncov
near
futur
advent
new
mass
spectrometri
techniqu
improv
tool
detect
adpribos
last
decad
seen
explos
understand
parp
adpribos
impact
immun
biolog
gener
technolog
develop
exponenti
facilit
parp
research
futur
parp
inhibitor
test
clinic
chemotherapi
like
parp
inhibitor
agonist
could
use
treat
immun
disord
well
howev
develop
parpspecif
inhibitor
agonist
challeng
still
long
way
go
fulli
understand
parp
function
cell
cultur
vivo
target
treatment
infect
immun
diseas
addit
parpdefici
anim
specif
inhibitor
need
gain
better
knowledg
parp
impact
pathogenesi
infect
immunemedi
diseas
parp
structur
function
distinct
specif
offtarget
effect
parp
inhibitor
remain
incomplet
understood
thu
character
compound
necessari
accumul
clinic
scientif
evid
support
theori
inflamm
promot
variou
global
health
threat
myocardi
infarct
howev
mechan
macrophag
activ
instanc
remain
obscur
recent
understand
macrophag
highli
heterogen
ad
complex
inflamm
role
parp
inflamm
via
enzymat
activitydepend
independ
mechan
specif
function
domain
macrophag
activ
furthermor
addit
role
parp
antivir
respons
like
exist
especi
parp
strong
posit
select
pressur
yet
associ
specif
biolog
activ
sever
case
mechan
use
parp
inhibit
specif
virus
remain
unknown
also
intrigu
sever
ifninduc
parp
shown
enhanc
viru
replic
could
mechan
host
maintain
minim
amount
viru
replic
vivo
immun
system
appropri
activ
answer
mani
question
great
interest
parp
research
immunologist
microbiologist
like
uncov
uniqu
cellular
process
regul
adpribosyl
could
lead
identif
novel
therapeut
target
infect
immunemedi
diseas
